The results of CCK‐8 show that the glioma cell viability was more robust in the CSF‐1 overexpression group but was significantly reduced in the group with CSF‐1 knockdown compared to that in the mock group (Figure 5B). The gene discussed is CSF1; the disease is central nervous system cancer.